Milestone Pharmaceuticals IncNASDAQ:MIST
- LAST PRICE3.9400
- TODAY'S CHANGE (%)0.1100 (2.8721%)
- Bid / Lots3.8300/ 1
- Ask / Lots4.0500/ 9
- Open / Previous Close3.8700 / 3.8300
- Day Range
- 52 Week Range
- Volume159,155
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIST |
|---|---|---|
| 09:32 ET | 327 | 3.87 |
| 09:34 ET | 441 | 3.92 |
| 09:38 ET | 540 | 3.865 |
| 09:39 ET | 739 | 3.865 |
| 09:41 ET | 1800 | 3.9 |
| 09:43 ET | 226 | 3.86 |
| 09:45 ET | 541 | 3.96 |
| 09:50 ET | 440 | 3.96 |
| 09:52 ET | 541 | 3.88 |
| 09:56 ET | 439 | 3.92 |
| 09:57 ET | 439 | 3.92 |
| 10:01 ET | 539 | 3.925 |
| 10:03 ET | 300 | 3.93 |
| 10:06 ET | 2986 | 3.945 |
| 10:08 ET | 449 | 3.95 |
| 10:12 ET | 3300 | 3.95 |
| 10:14 ET | 3474 | 3.9 |
| 10:21 ET | 440 | 3.935 |
| 10:24 ET | 814 | 3.9446 |
| 10:26 ET | 1600 | 4 |
| 10:28 ET | 200 | 4 |
| 10:30 ET | 3094 | 3.975 |
| 10:32 ET | 100 | 3.95 |
| 10:33 ET | 1200 | 3.97 |
| 10:35 ET | 600 | 3.9881 |
| 10:37 ET | 2300 | 3.97 |
| 10:39 ET | 1100 | 3.97 |
| 10:42 ET | 100 | 3.97 |
| 10:44 ET | 200 | 3.97 |
| 10:48 ET | 100 | 3.97 |
| 10:50 ET | 1122 | 3.98 |
| 10:51 ET | 1000 | 3.982 |
| 10:53 ET | 200 | 3.99 |
| 10:55 ET | 100 | 3.98 |
| 10:57 ET | 538 | 3.98 |
| 11:02 ET | 1263 | 4 |
| 11:04 ET | 18999 | 3.96 |
| 11:06 ET | 4632 | 3.98 |
| 11:08 ET | 200 | 3.975 |
| 11:11 ET | 2040 | 4.01 |
| 11:13 ET | 2336 | 3.98 |
| 11:15 ET | 200 | 3.99 |
| 11:18 ET | 100 | 3.99 |
| 11:20 ET | 839 | 4.01 |
| 11:22 ET | 200 | 4.03 |
| 11:24 ET | 1100 | 4.0329 |
| 11:26 ET | 5200 | 4 |
| 11:27 ET | 100 | 4.025 |
| 11:29 ET | 999 | 4.05 |
| 11:31 ET | 200 | 4.01 |
| 11:33 ET | 200 | 4 |
| 11:36 ET | 400 | 4.0087 |
| 11:44 ET | 511 | 3.97 |
| 11:45 ET | 300 | 4.0299 |
| 11:51 ET | 400 | 3.92 |
| 11:56 ET | 100 | 3.93 |
| 12:00 ET | 2785 | 3.87 |
| 12:03 ET | 100 | 3.84 |
| 12:07 ET | 100 | 3.845 |
| 12:09 ET | 100 | 3.89 |
| 12:12 ET | 100 | 3.855 |
| 12:14 ET | 2200 | 3.9 |
| 12:16 ET | 5418 | 3.94 |
| 12:18 ET | 200 | 3.97 |
| 12:21 ET | 100 | 3.94 |
| 12:25 ET | 100 | 3.945 |
| 12:27 ET | 1600 | 3.95 |
| 12:30 ET | 200 | 3.9204 |
| 12:32 ET | 100 | 3.925 |
| 12:36 ET | 100 | 3.925 |
| 12:38 ET | 100 | 3.92 |
| 12:39 ET | 300 | 3.92 |
| 12:41 ET | 200 | 3.92 |
| 12:43 ET | 200 | 3.93 |
| 12:45 ET | 100 | 3.92 |
| 12:48 ET | 3400 | 3.85 |
| 12:50 ET | 200 | 3.85 |
| 12:52 ET | 800 | 3.85 |
| 12:54 ET | 200 | 3.85 |
| 12:56 ET | 600 | 3.85 |
| 12:57 ET | 400 | 3.85 |
| 12:59 ET | 300 | 3.85 |
| 01:01 ET | 1200 | 3.845 |
| 01:03 ET | 700 | 3.845 |
| 01:06 ET | 300 | 3.845 |
| 01:08 ET | 400 | 3.845 |
| 01:10 ET | 100 | 3.845 |
| 01:12 ET | 100 | 3.845 |
| 01:14 ET | 100 | 3.845 |
| 01:15 ET | 200 | 3.845 |
| 01:21 ET | 100 | 3.85 |
| 01:26 ET | 700 | 3.85 |
| 01:28 ET | 200 | 3.85 |
| 01:32 ET | 200 | 3.88 |
| 01:39 ET | 2800 | 3.85 |
| 01:42 ET | 137 | 3.85 |
| 01:44 ET | 200 | 3.85 |
| 01:46 ET | 200 | 3.85 |
| 01:48 ET | 600 | 3.85 |
| 01:50 ET | 300 | 3.85 |
| 01:51 ET | 100 | 3.83 |
| 01:53 ET | 2800 | 3.92 |
| 01:55 ET | 800 | 3.93 |
| 01:57 ET | 200 | 3.92 |
| 02:00 ET | 1000 | 3.95 |
| 02:02 ET | 1800 | 4 |
| 02:06 ET | 100 | 3.97 |
| 02:09 ET | 100 | 3.97 |
| 02:18 ET | 200 | 4 |
| 02:20 ET | 100 | 3.99 |
| 02:22 ET | 100 | 3.96 |
| 02:24 ET | 3200 | 3.99 |
| 02:26 ET | 2390 | 3.985 |
| 02:29 ET | 100 | 3.97 |
| 02:33 ET | 400 | 4 |
| 02:36 ET | 900 | 4 |
| 02:38 ET | 100 | 3.9775 |
| 02:42 ET | 100 | 3.985 |
| 02:44 ET | 100 | 3.985 |
| 02:45 ET | 100 | 3.98 |
| 02:49 ET | 100 | 3.95 |
| 02:54 ET | 500 | 3.96 |
| 02:58 ET | 600 | 3.96 |
| 03:00 ET | 802 | 4 |
| 03:02 ET | 3085 | 4 |
| 03:18 ET | 100 | 3.915 |
| 03:20 ET | 100 | 3.91 |
| 03:23 ET | 300 | 3.91 |
| 03:25 ET | 300 | 3.92 |
| 03:30 ET | 100 | 3.84 |
| 03:32 ET | 100 | 3.84 |
| 03:34 ET | 5865 | 3.935 |
| 03:36 ET | 100 | 3.965 |
| 03:38 ET | 100 | 3.935 |
| 03:39 ET | 500 | 3.92 |
| 03:41 ET | 100 | 3.92 |
| 03:43 ET | 3400 | 4 |
| 03:45 ET | 200 | 4.01 |
| 03:50 ET | 4131 | 3.97 |
| 03:54 ET | 100 | 3.97 |
| 03:56 ET | 400 | 3.93 |
| 03:57 ET | 200 | 3.93 |
| 03:59 ET | 3206 | 3.94 |
Mar 29, 2023
BRIEF-Milestone Pharmaceuticals Posts Q4 Loss Per Share $0.31, from 11:10AM ET on Wednesday Mar 29, 2023 by Thomson Reuters
11:10AM ET on Wednesday Mar 29, 2023 by Thomson Reuters-- Earnings Flash (MIST) MILESTONE PHARMACEUTICALS Posts Q4 Revenue $3.5M, from 9:34AM ET on Wednesday Mar 29, 2023 by MT Newswires
9:34AM ET on Wednesday Mar 29, 2023 by MT NewswiresMilestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update, from 9:18AM ET on Wednesday Mar 29, 2023 by PR Newswire
9:18AM ET on Wednesday Mar 29, 2023 by PR Newswire
Mar 28, 2023
Milestone Pharmaceuticals Signs $125 Million Financing Deal With RTW Investments; Shares Rise, from 10:39AM ET on Tuesday Mar 28, 2023 by MT Newswires
10:39AM ET on Tuesday Mar 28, 2023 by MT NewswiresBRIEF-Milestone Pharmaceuticals Announces $125 Million Strategic Financing With RTW Investments To Support The Advancement Of Etripamil For PSVT, from 10:33AM ET on Tuesday Mar 28, 2023 by Thomson Reuters
10:33AM ET on Tuesday Mar 28, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Milestone Pharmaceuticals Inc | 131.2M | -2.9x | --- |
Invivyd Inc | 131.0M | -0.5x | --- |
ESSA Pharma Inc | 131.0M | -4.0x | --- |
Anixa Biosciences Inc | 133.0M | -10.9x | --- |
Enzolytics Inc | 133.0M | -0.4x | --- |
Nanobiotix SA | 123.4M | -2.6x | --- |
Company Information
Milestone Pharmaceuticals, Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent and short-acting calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is developing etripamil for the treatment of arrhythmias with an indication to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Contact Information
- Headquarters
- 420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
- Phone
- 514-336-0444
- Fax
- 514-336-0444
Executives
- Non-Executive Independent Chairman of the Board
- Robert Wills
- President, Chief Executive Officer, Director
- Joseph Oliveto
- Chief Financial Officer, Executive Vice President of Corporate Development
- Amit Hasija
- Chief Medical Officer
- David Bharucha
- Chief Commercial Officer
- Lorenz Muller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $131.2M |
|---|---|
Revenue (TTM) | $5.0M |
Shares Outstanding | 33.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.02 |
EPS | $-1.38 |
Book Value | $1.94 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | 26.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,192.84% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
